IMMUNOGENIC COMPOSITIONS CONTAINING RECOMBINANT ATTENUATED POXVIRUSES EXPRESSING HTLV ANTIGENS - Patent 0805854

(19)

(11)

EP 0 805 854 A1

(12)

(43)	Date of publication:
	12.11.1997 Bulletin 1997/46

(21)	Application number: 96902688.0

(22)	Date of filing: 16.01.1996

(51)

International Patent Classification (IPC):

C12N 15/ 09^{( . )}
A61K 39/ 21^{( . )}
A61K 39/ 395^{( . )}
C07K 14/ 145^{( . )}
C07K 16/ 08^{( . )}
C12N 15/ 863^{( . )}
C12P 21/ 04^{( . )}

A61K 39/ 205^{( . )}
A61K 39/ 275^{( . )}
A61P 31/ 12^{( . )}
C07K 14/ 15^{( . )}
C12N 7/ 00^{( . )}
C12P 21/ 02^{( . )}
A61K 39/ 00^{( . )}

(86)	International application number:
	PCT/US1996/000547

(87)	International publication number:
	WO 1996/021727 (18.07.1996 Gazette 1996/33)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

13.01.1995 US 19950372664

(60)	Divisional application:
	07075029.4 / 1840209

(71)	Applicant: VIROGENETICS CORPORATION
	Troy, NY 12180 (US)

(72)	Inventors:
	PAOLETTI, Enzo Delmar, NY 12054 (US) TARTAGLIA, James Schenectady, NY 12303 (US) FRANCHINI, Genoveffa Washington, DC 20011 (US) GALLO, Robert, C. Bethesda, MD 20817 (US)

(74)	Representative: Mallalieu, Catherine Louise, et al
	D. Young & Co., 21 New Fetter Lane London EC4A 1DA London EC4A 1DA (GB)

(54)	IMMUNOGENIC COMPOSITIONS CONTAINING RECOMBINANT ATTENUATED POXVIRUSES EXPRESSING HTLV ANTIGENS